CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.1500
-0.0200 (-1.71%)
At close: 3:56PM EST
Stock chart is not supported by your current browser
Previous Close1.1700
Open1.2302
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.1483 - 1.2302
52 Week Range0.7800 - 4.7800
Volume69,717
Avg. Volume128,289
Market Cap213.759M
Beta (5Y Monthly)N/A
PE Ratio (TTM)4.42
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations

    TORONTO , Jan. 17, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis operations. Two portfolio companies are evaluating opportunities to expand their retail footprint in Canada , while another will remember 2019 as the year it grew its retail presence across the U.S., Canada , and Europe . Another Canopy Rivers portfolio company is taking steps to build out its U.S. operations, as more states look to legalize medical or recreational cannabis.

  • 115 cannabis drink companies are taking aim at booze and soda
    Yahoo Finance Canada

    115 cannabis drink companies are taking aim at booze and soda

    Beer, wine and spirit giants and small startups alike are betting on cannabis beverages disrupting the drinks market with products that can soothe sore muscles after a workout, or deliver a hangover-free buzz. 

  • Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
    CNW Group

    Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

    TORONTO, Jan. 8, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medical cannabis. While BioLumic's approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%, this approval marks the first time the company's UV light technology will be used on cannabis.

  • Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note

    TORONTO , Dec. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies made several announcements that demonstrate the portfolio's continued growth heading into 2020. Among others, this includes new features from a business intelligence and analytics software platform, a licensed producer responding to consumer demands for high-THC products with the launch of four new cannabis strains, and a portfolio company expanding its retail footprint. Headset, Inc. ("Headset") launched the Demand Planning add-on to help its customers understand the "when" of the retail cannabis industry.

  • Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board
    CNW Group

    Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board

    Advisory board role marks star-backed venture firm's first exposure to Canadian cannabis sector TORONTO , Nov. 26, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers ") (TSX: RIV, OTC: CNPOF), ...

  • Rivers Rundown: Canopy Rivers Portfolio Companies Expand Operations, Leadership
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Expand Operations, Leadership

    Rivers Rundown: Canopy Rivers Portfolio Companies Expand Operations, Leadership

  • Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
    CNW Group

    Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update

    TORONTO , Nov. 14, 2019 /CNW/ - Canopy Rivers Inc. (the " Company " or " Canopy Rivers ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its ...

  • Rivers Rundown: Canopy Rivers Portfolio Companies Prepare for Cannabis 2.0
    CNW Group

    Rivers Rundown: Canopy Rivers Portfolio Companies Prepare for Cannabis 2.0

    Canopy Rivers provides update on TerrAscend, JWC, and Radicle TORONTO , Nov. 7, 2019 /CNW/ - As cannabis 2.0 rolls out across Canada , several Canopy Rivers Inc. (" Canopy Rivers ") (TSX: RIV, ...

  • Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence
    CNW Group

    Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence

    TORONTO, Oct. 24, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval for oil sales from Health Canada. This additional licence allows for the development and sale of new cannabis products, including cannabis oil and concentrates.  This opens the door for Radicle's medical patients to access other product forms in the company's craft cannabis selection.

  • Canopy Rivers and Kindred Launch Strategic Alliance to Elevate Products & Brands
    CNW Group

    Canopy Rivers and Kindred Launch Strategic Alliance to Elevate Products & Brands

    TORONTO , Oct. 23, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and Kindred Partners Inc. (" Kindred "), ...

  • Canopy Rivers to Report Second Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
    CNW Group

    Canopy Rivers to Report Second Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO, Oct. 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its second quarter fiscal year 2020 financial results before markets open on Thursday, November 14, 2019. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on November 14, 2019.

  • Market Exclusive

    Canopy Rivers Gets Approval to Boost Cannabis Production

    James E. Wagner Cultivation (TSXV: JWCA) (OTCQX: JWCAF), a portfolio company of Canopy Rivers (TSX: RIV) (OTC: CNPOF), has been granted approval by Health Canada to increase cannabis production at its facility in Kitchener, Ontario. The approval allows the company to start the production in four new flowering rooms at its facility in Kitchener. The additional […]The post Canopy Rivers Gets Approval to Boost Cannabis Production appeared first on Market Exclusive.

  • Canopy Rivers Portfolio Company Receives Milestone Health Canada Licence Amendment
    CNW Group

    Canopy Rivers Portfolio Company Receives Milestone Health Canada Licence Amendment

    TORONTO, Oct. 15, 2019 /CNW/ - Canopy Rivers ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) received a Health Canada licence amendment allowing for cannabis production in four new flowering rooms at its flagship facility in Kitchener, Ontario. "We believe that this licence amendment demonstrates Health Canada's recognition of JWC, the quality of its operations, and its disciplined approach to expansion," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers. "Through its supply agreement with TerrAscend, JWC has an active role in the Canopy Rivers ecosystem.

  • Canopy Rivers Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure
    CNW Group

    Canopy Rivers Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure

    TORONTO , Oct. 7, 2019 /CNW/ - Canopy Rivers Inc. (the " Canopy Rivers ") (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. (" TerrAscend ") (CSE: ...

  • Canopy Rivers Invests In TerrAscend
    CNW Group

    Canopy Rivers Invests In TerrAscend

    The principal amount of the Debentures is convertible into fully paid and non-assessable common shares of TerrAscend ("Common Shares") or exchangeable shares of TerrAscend ("Exchangeable Shares") at the option of the holder or upon the occurrence of certain events at a conversion price of $5.95 per share.

  • Canopy Rivers Invests Additional US $10 Million in TerrAscend
    CNW Group

    Canopy Rivers Invests Additional US $10 Million in TerrAscend

    TORONTO, Oct. 2, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has completed a US $10 million investment (the "Investment") in TerrAscend Canada Inc. ("TerrAscend Canada"), a subsidiary of its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The investment includes the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of CA $1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend exercisable until October 2, 2024 (the "Warrants").

  • Canopy Rivers Inc. announces results of annual general and special meeting of shareholders
    CNW Group

    Canopy Rivers Inc. announces results of annual general and special meeting of shareholders

    TORONTO , Sept. 26, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced ...

  • GlobeNewswire

    Investor Ideas Potcast- Cannabis News and Stocks on the Move; You Can’t Keep a Good Plant Down- Thought Leaders Share High Expectations for Cannabis Sector

    When asked about the recent announcement involving Convectium/Jacksam, Mr. Ralston commented, "Convectium was founded on the basis that automation, speed, hardware and technology combined for the ancillary cannabis space can really help these manufacturers and retailers make their whole filling and supply chain process much simpler and efficient. Discussing what separates Convectium from some of their competitors, Ralston said, "Right now Convectium, in our opinion, is really leading the way because they check all the boxes for what a company may need when it comes to filling and getting these automation systems set up. SinglePoint Inc. will also be presenting their Pure Hemp Cigarettes next month at NACS on October 1st - 4th at booth 5653.

  • Canopy Rivers Portfolio Company Licenses Leading Medical Cannabis Vape Technology in Canada
    CNW Group

    Canopy Rivers Portfolio Company Licenses Leading Medical Cannabis Vape Technology in Canada

    TORONTO, Sept. 17, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX:RIV.V - News) (OTC:CNPOF - News), a venture capital firm specializing in cannabis, is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE:TER.CN - News) (OTCQX:TRSSF - News), has entered into a distribution agreement with Syqe Medical, Ltd. ("Syqe"), an Israel-based pharma-tech company, to launch Syqe's flagship product, the Syqe™ Inhaler, in Canada. The Syqe Inhaler is the world's first metered-dose medical cannabis inhaler and will provide Canadians with an alternative to dried flower medical cannabis.